Distal myopathies

I Pénisson-Besnier1

  • 1Département de neurologie, centre de référence des maladies neuromusculaires, centre hospitalier et universitaire d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.

Revue Neurologique
|September 7, 2013
PubMed

Insights

Distal myopathies are genetic muscle disorders affecting muscles of the limbs. Recent advances identify fourteen distinct types, aiding clinicians in diagnosing these rare diseases.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Distal myopathies are a diverse group of genetic neuromuscular disorders.
  • Characterized by weakness primarily in distal muscles.
  • Pathological findings confirm a myopathic process.

Purpose of the Study:

  • To review the clinical and genetic characteristics of identified distal myopathies.
  • To highlight recent findings in the field.
  • To provide clinicians with an overview for molecular diagnosis.

Main Methods:

  • Literature review of clinical and genetic data.
  • Analysis of identified genes and causative mutations.
  • Summary of diagnostic indicators.

Main Results:

  • Fourteen distinct distal myopathies are now defined by gene and mutation.
  • Previously, only five entities were recognized clinically.
  • Affected proteins include various types, notably sarcomeric proteins.

Conclusions:

  • The genetic landscape of distal myopathies has expanded significantly.
  • Clinical indicators like inheritance, onset, muscle pattern, CK levels, and pathology guide diagnosis.
  • This review synthesizes current knowledge for improved understanding and diagnosis.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...